Cargando…
Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
Treatment of extensive or recalcitrant alopecia areata (AA) is a major clinical challenge. Even after thorough investigation of several medications, its treatment outcomes have remained unsatisfactory. While there is no US Food and Drug Administration-approved medication for AA yet, topical immunoth...
Autores principales: | Mahasaksiri, Thipprapai, Kositkuljorn, Chaninan, Anuntrangsee, Tanaporn, Suchonwanit, Poonkiat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001176/ https://www.ncbi.nlm.nih.gov/pubmed/33790540 http://dx.doi.org/10.2147/DDDT.S297858 |
Ejemplares similares
-
Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
por: Chanprapaph, Kumutnart, et al.
Publicado: (2021) -
Alopecia Areata: An Autoimmune Disease of Multiple Players
por: Suchonwanit, Poonkiat, et al.
Publicado: (2021) -
Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis
por: Chanprapaph, Kumutnart, et al.
Publicado: (2022) -
Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018) -
Trichostasis Spinulosa: A Case Report with an Unusual Presentation
por: Kositkuljorn, Chaninan, et al.
Publicado: (2020)